Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Activated Lymphocyte Injection in Stage 4 Solid Cancer Patients
KCT0006567Phase 2Recruiting
- Sponsor
- G-SAM Hospital
- Start
- May 2016
- Countries
- 1
01
Overview
A Phase 2 trial of autologous activated lymphocytes in bronchial carcinoma, gastric cancer (GC), colorectal cancer (CRC), pancreatic cancer (PC), ovarian cancer, sponsored by G-SAM Hospital. Started May 2016; status: recruiting.
02
Drugs
autologous activated lymphocytes
03
Conditions
bronchial carcinomagastric cancer (GC)colorectal cancer (CRC)pancreatic cancer (PC)ovarian cancer
Beyond the preview
Go deeper on KCT0006567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006567.